These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Bivalirudin: a direct thrombin inhibitor. Gladwell TD Clin Ther; 2002 Jan; 24(1):38-58. PubMed ID: 11833835 [TBL] [Abstract][Full Text] [Related]
3. Bivalirudin, a bivalent, thrombin specific anticoagulant as an alternative to heparin in interventional procedures as an alternative to heparin in interventional procedures. Chew DP Hamostaseologie; 2002 Aug; 22(3):60-6. PubMed ID: 12215763 [TBL] [Abstract][Full Text] [Related]
4. Bivalirudin: a review of its potential place in the management of acute coronary syndromes. Carswell CI; Plosker GL Drugs; 2002; 62(5):841-70. PubMed ID: 11929334 [TBL] [Abstract][Full Text] [Related]
5. Clinical pharmacology of bivalirudin. Reed MD; Bell D Pharmacotherapy; 2002 Jun; 22(6 Pt 2):105S-111S. PubMed ID: 12064567 [TBL] [Abstract][Full Text] [Related]
6. Bivalirudin: a review of the pharmacology and clinical application. Van De Car DA; Rao SV; Ohman EM Expert Rev Cardiovasc Ther; 2010 Dec; 8(12):1673-81. PubMed ID: 21108549 [TBL] [Abstract][Full Text] [Related]
7. Bivalirudin: pharmacology and clinical applications. Shammas NW Cardiovasc Drug Rev; 2005; 23(4):345-60. PubMed ID: 16614733 [TBL] [Abstract][Full Text] [Related]
8. Pharmacology and clinical use of bivalirudin. Sciulli TM; Mauro VF Ann Pharmacother; 2002 Jun; 36(6):1028-41. PubMed ID: 12022907 [TBL] [Abstract][Full Text] [Related]
9. The use of bivalirudin in patients with renal impairment. Robson R J Invasive Cardiol; 2000 Dec; 12 Suppl F():33F-6. PubMed ID: 11156732 [TBL] [Abstract][Full Text] [Related]
10. Bivalent direct thrombin inhibitors: hirudin and bivalirudin. Warkentin TE Best Pract Res Clin Haematol; 2004 Mar; 17(1):105-25. PubMed ID: 15171961 [TBL] [Abstract][Full Text] [Related]
11. Bivalirudin (Angiomax) for angioplasty. Med Lett Drugs Ther; 2001 Apr; 43(1103):37-8. PubMed ID: 11331441 [No Abstract] [Full Text] [Related]
12. Bivalirudin compared with heparin during coronary angioplasty for thrombus-containing lesions. Shah PB; Ahmed WH; Ganz P; Bittl JA J Am Coll Cardiol; 1997 Nov; 30(5):1264-9. PubMed ID: 9350925 [TBL] [Abstract][Full Text] [Related]
13. Bivalirudin: a review of its use in patients undergoing percutaneous coronary intervention. Moen MD; Keating GM; Wellington K Drugs; 2005; 65(13):1869-91. PubMed ID: 16114983 [TBL] [Abstract][Full Text] [Related]
14. Thrombin inhibitor approved for anticoagulation during angioplasty. Lieder TR Am J Health Syst Pharm; 2001 Mar; 58(5):363. PubMed ID: 11258166 [No Abstract] [Full Text] [Related]
16. Bivalirudin administration during percutaneous coronary intervention: emphasis on high-risk patients. Seybert AL Pharmacotherapy; 2002 Jun; 22(6 Pt 2):112S-118S. PubMed ID: 12064568 [TBL] [Abstract][Full Text] [Related]
17. Bivalirudin with planned or provisional abciximab versus low-dose heparin and abciximab during percutaneous coronary revascularization: results of the Comparison of Abciximab Complications with Hirulog for Ischemic Events Trial (CACHET). Lincoff AM; Kleiman NS; Kottke-Marchant K; Maierson ES; Maresh K; Wolski KE; Topol EJ Am Heart J; 2002 May; 143(5):847-53. PubMed ID: 12040347 [TBL] [Abstract][Full Text] [Related]
18. Bivalirudin: a new generation antithrombotic drug. Scatena R Expert Opin Investig Drugs; 2000 May; 9(5):1119-27. PubMed ID: 11060732 [TBL] [Abstract][Full Text] [Related]
19. Use of bivalirudin as an anticoagulant during cardiopulmonary bypass. Veale JJ; McCarthy HM; Palmer G; Dyke CM J Extra Corpor Technol; 2005 Sep; 37(3):296-302. PubMed ID: 16350384 [TBL] [Abstract][Full Text] [Related]